Buspirone

• Description:

  Buspirone is an orally active 5-HT1A receptor agonist, and a dopamine D2 autoreceptorsant antagonist. Buspirone is an anxiolytic agent, and can be used for the generalized anxiety disorder research[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H301

• Target:

  5-HT Receptor; Dopamine Receptor; Reactive Oxygen Species (ROS)

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/buspirone.html

• Purity:

  99.86

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  O=C(N(CCCCN1CCN(C2=NC=CC=N2)CC1)C(C3)=O)CC43CCCC4

• Molecular Formula:

  C21H31N5O2

• Molecular Weight:

  385.50

• Precautions:

  H301

• References & Citations:

  [1]Salimi A, et, al. Analysis of Toxicity Effects of Buspirone, Cetirizine and Olanzapine on Human Blood Lymphocytes: in Vitro Model. Curr Clin Pharmacol. 2018;13 (2) :120-127.|[2]Kim JK, et, al. Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice. Sci Rep. 2021 Mar 17;11 (1) :6094.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  Launched

• Isoform:

  5-HT1 Receptor; D2 Receptor; mLAG-3

• Citation 01:

  Clin Pharmacol Ther. 2025 Jul 14.|Mol Pharmacol. 2023 Nov;104 (5) :230-238.

• CAS Number:

  [36505-84-7]